The Johnson & Johnson vaccine explained: Why its 66% effectiveness of Covid is a ‘game changer’ in the fight against the pandemic
Johnson & Johnson’s COVID-19 vaccine is 85% effective against severe cases and 66% effective overall by trial data
The Johnson & Johnson Covid-19 vaccine is 66% effective in global testing, but 85% effective against serious illnesses, says the company